20/12/2024
張先生今年45歲,過去兩年飽受勃起功能障礙(ED)困擾,逐漸影響他與妻子的親密關係,也讓他的自信心跌落谷底。嘗試過傳統藥物後效果不佳,張先生開始尋求其他治療選擇。他聽說了新興的再生療法,例如體外震波療法(ESWT)、富血小板血漿(PRP)及幹細胞注射,但卻對各種療法的安全性及效果感到疑惑。
經過深入了解,張先生發現ESWT臨床試驗具有更嚴謹的納入標準,且最常用國際勃起功能指數(IIEF)分數來評估效果。他決定參加一項ESWT臨床試驗,經過多次療程,逐漸感受到改善。與此同時,他也關注到PRP和幹細胞療法的臨床試驗主要關注安全性,顯示出這些療法仍處於實驗階段。
如今,張先生重新找回了身心的平衡,夫妻關係也更加融洽。他表示,臨床試驗不僅給予他治療機會,也讓他了解再生療法的差異性,成為他尋找希望的起點。
#線性震波
#低能量震波
#體外震波
Urology 2024 Jul:189:135-143
Variability in Methodology of Erectile Dysfunction Regenerative Therapy Trials on ClinicalTrials.gov
Conclusion: There is substantial variability in the inclusion/exclusion criteria and outcome measures among ED regenerative therapy trials. ESWT trials most frequently utilized IIEF and had the strictest inclusion/exclusion criteria, suggesting more rigorous and functional outcome-based studies. Conversely, PRP/SC and ORT trials, but not ESWT trials, had safety/tolerability as a primary outcome, likely due to the experimental nature of these therapies. The variability in inclusion/exclusion criteria and outcome measures limits comparison of the various ED regenerative therapies.
「 #德國聚焦式震波」「 #體外震波治療」,「 #低能量震波治療」「 #低能量體外震波治療,"線性震波治療"